November 6, 2017 โ TeraRecton announced the launch of version 4.4.13 of its iNtuition advanced visualization platform ...
November 6, 2017 โ One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...
November 6, 2017 โ The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 6, 2017 โ Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...
November 6, 2017 โ Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...
November 6, 2017 โ The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 3, 2017 โ Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...
November 3, 2017 โ A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...
November 3, 2017 โ Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 3, 2017 โ VitalConnect Inc. announced the fourth and final Series C closing, bringing the total Series C round ...
Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini System, the next-generation system of its RXi Rapid Exchange FFR System. The RXi Mini System debuted at the 29th Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 2 in Denver.
November 2, 2017 โ Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 2, 2017 โ The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...
November 2, 2017 โ Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...
OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 2 in Denver. The results provide fresh insights into the optimal treatment of patients with acute coronary syndrome (ACS) using the COMBO Dual Therapy Stent.